Colistimethate (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Colistimethate drug offered from Par Pharmaceutical, Inc.. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: colistimethate sodium
SUBSTANCE NAME: COLISTIMETHATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2012-06-01
END MARKETING DATE: 0000-00-00


Colistimethate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionColistimethate from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/2mL)
START MARKETING DATE: 2012-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42023-131_8bc2cc86-e415-4960-9f43-10729ea553c3
PRODUCT NDC: 42023-131
APPLICATION NUMBER: NDA050108

Other COLISTIMETHATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCColistimethate
Heritage Pharmaceuticals Inc.COLISTIMETHATE SODIUM
Paddock Laboratories, LLCColistimethate
Par Pharmaceutical, Inc.Coly-Mycin
Sagent PharmaceuticalsColistimethate
X-GEN Pharmaceuticals, Inc.Colistimethate